PDCD case monitored by localized proton magnetic resonance spectroscopy
7 evidence topics · 1 source
Objective
Location and study date
No evidence found.
Study design
Eligibility criteria
No evidence found.
Treatment
Study outcomes
Rationale for using brain lactate as a biochemical outcome
Biochemical monitoring method
Validation as a predictor of clinical benefit
No evidence found.
Statistical analysis description
Number of participants (Planned and analyzed)
Reported participant
Description of analysis sets
Not applicable.
Results
Participant disposition
No evidence found.
Baseline characteristics
Clinical diagnosis and age at initial spectroscopy
Efficacy results
Health-related quality of life and patient-reported outcomes
No evidence found.
Safety results
No evidence found.
Study limitations
Summary
This single-case observation links treatment withdrawal with increased brain lactate and recurrent convulsions. It lacks a randomized comparison and cannot establish a general treatment effect, a validated surrogate relationship, or the incidence of treatment-related harm.